Literature DB >> 11750880

Thrombopoietin: a pan-hematopoietic cytokine.

Amy E Geddis1, Hannah M Linden, Kenneth Kaushansky.   

Abstract

The recent discovery of thrombopoietin has enhanced our understanding of both hematopoiesis and platelet production. Thrombopoietin supports hematopoietic stem cell survival and expansion as well as promoting all aspects of megakaryocyte development. The hormone displays many structural similarities to other members of the hematopoietic cytokine family and some notable differences, and regulation of its expression requires both receptor-mediated removal and other mechanisms. Thrombopoietin induces receptor dimerization and tyrosine phosphorylation, and a series of signaling events including activation of JAK/STAT, Shc/Ras/MAPK and PI3K/Akt; these pathways overlap with those induced by other cytokines, but the differences that lead to the unique biological effects of the hormone are gradually being uncovered. Our growing appreciation of how cytokine signaling pathways are translated into megakaryocyte development is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11750880     DOI: 10.1016/s1359-6101(01)00030-2

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  22 in total

1.  Pharmacodynamics-mediated drug disposition (PDMDD) and precursor pool lifespan model for single dose of romiplostim in healthy subjects.

Authors:  Yow-Ming C Wang; Wojciech Krzyzanski; Sameer Doshi; Jim J Xiao; Juan Jose Pérez-Ruixo; Andrew T Chow
Journal:  AAPS J       Date:  2010-10-21       Impact factor: 4.009

2.  Inhibition of GSK-3beta promotes survival and proliferation of megakaryocytic cells through a beta-catenin-independent pathway.

Authors:  Mie Soda; Karl Willert; Kenneth Kaushansky; Amy E Geddis
Journal:  Cell Signal       Date:  2008-09-06       Impact factor: 4.315

3.  Investigation of the pharmacokinetics of romiplostim in rodents with a focus on the clearance mechanism.

Authors:  Yow-Ming C Wang; Bethlyn Sloey; Teresa Wong; Prerna Khandelwal; Rebeca Melara; Yu-Nien Sun
Journal:  Pharm Res       Date:  2011-04-08       Impact factor: 4.200

4.  The radiation protection and therapy effects of mesenchymal stem cells in mice with acute radiation injury.

Authors:  K X Hu; Q Y Sun; M Guo; H S Ai
Journal:  Br J Radiol       Date:  2010-01       Impact factor: 3.039

Review 5.  Megakaryopoiesis.

Authors:  Amy E Geddis
Journal:  Semin Hematol       Date:  2010-07       Impact factor: 3.851

6.  Identification of a new Mpl-interacting protein, Atp5d.

Authors:  Hongyan Liu; Zhenhu Zhao; Yuxu Zhong; Yajun Shan; Xiaohong Sun; Bingzhi Mao; Yuwen Cong
Journal:  Mol Cell Biochem       Date:  2014-03-11       Impact factor: 3.396

7.  Analysis of thrombocyte development in CD41-GFP transgenic zebrafish.

Authors:  Hui-Feng Lin; David Traver; Hao Zhu; Kimberly Dooley; Barry H Paw; Leonard I Zon; Robert I Handin
Journal:  Blood       Date:  2005-08-11       Impact factor: 22.113

8.  Pharmacokinetic and pharmacodynamic modeling of romiplostim in animals.

Authors:  Wojciech Krzyzanski; Liviawati Sutjandra; Juan Jose Perez-Ruixo; Bethlyn Sloey; Andrew T Chow; Yow-Ming Wang
Journal:  Pharm Res       Date:  2012-12-19       Impact factor: 4.200

Review 9.  Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura.

Authors:  Roberto Stasi; Maria L Evangelista; Sergio Amadori
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  MicroRNA 4323 induces human bladder smooth muscle cell proliferation under cyclic hydrodynamic pressure by activation of erk1/2 signaling pathway.

Authors:  Yi Sun; Deyi Luo; Yuchun Zhu; Kunjie Wang
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.